Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

2.990 -0.070 (-2.29%)
Streaming Delayed Price Updated: 10:37 AM EST, Feb 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads. 
Via Benzinga
News headline image
Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About Evolent Health ↗
Within the last quarter, Evolent Health (NYSE:EVH) has observed the following analyst ratings: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Can Biotech Stocks Continue Rallying In This Bear Market? ↗
Via Talk Markets
News headline image
Privia Health Stock Receives IBD Stock Rating Upgrade ↗
On Monday, Privia Health stock saw an improvement in its IBD SmartSelect Composite Rating, upgrading to 96 from 94. 
Via Investor's Business Daily
News headline image
Expert Ratings for Evolent Health ↗
Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Evolent Health ↗
Within the last quarter, Evolent Health (NYSE:EVH) has observed the following analyst ratings: 
Via Benzinga
News headline image
Evolent Expands Its Portfolio For Musculoskeletal Conditions With This Deal ↗
 
Via Benzinga
News headline image
Chicago Faith Leaders Plan Coordinated Sermons to Destigmatize Mental Health in Underserved Communities
From Evolent Health
Via Business Wire
Watch for Continued Gains in Shares of Evolent Health Inc Class A (EVH)
Via Investor Brand Network
Watch for Continued Gains in Shares of Evolent Health Inc Class A (EVH)
Via Investor Brand Network
News headline image
Whither Small Caps After Fed’s Tough Talk? ↗
For now its better not to “Fight the Fed” because they are fighting the with the market. Now that everyone is scared of the Fed's rhetoric it would be better to wait a week or so as more data and... 
Via Talk Markets
News headline image
Veeva Systems Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold ↗
Veeva Systems stock reached a key technical milestone, with its Relative Strength Rating, rising to 81 on Tuesday, up from 66 the day before. 
Via Investor's Business Daily
News headline image
4 Analysts Have This to Say About Evolent Health ↗
Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation? ↗
The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring... 
Via Talk Markets
News headline image
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review ↗
The Nasdaq and small caps rose while the S&P 500 is hitting resistance. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Applied DNA Sciences (NASDAQ:APDN) stock rose 90.0% to $5.32 during Tuesday's after-market session. At the close, Applied DNA Sciences's trading volume reached 28.8 million shares. This is... 
Via Benzinga
News headline image
Evolent Health Is In Buy Zone Ahead Of Earnings Announcement ↗
Medical cost management firm Evolent Health reports late Tuesday. 
Via Investor's Business Daily
News headline image
Evolent Health's Earnings: A Preview ↗
Evolent Health (NYSE:EVH) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Evolent Health... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022 ↗
  
Via Benzinga
News headline image
Amazon's Acquisition Of One Medical Rattles Health Care Stocks ↗
Amazon health care expansion plans, including its $3.9 billion acquisition of One Medical for about $3.9 billion, shook health care stocks. 
Via Investor's Business Daily
News headline image
Small Cap Biotechs Regain Momentum ↗
Smaller cap biotech stocks soared off from recent lows looking like a redux of early 2021 when prices were double that of current values. 
Via Talk Markets
News headline image
Simulations Plus Stock Scores Composite Rating Move Up To 96 ↗
The IBD SmartSelect Composite Rating for Simulations Plus stock rose from 94 to 96 Wednesday. The medical software stock has 94 RS Rating. 
Via Investor's Business Daily
News headline image
Bear Market Rally Lifts HealthCare Stocks Off Bottom ↗
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma. 
Via Talk Markets
News headline image
Privia Health Stock Among The Few That've Risen This Month ↗
Privia Health is trying to complete a cup without handle with a 29.07 entry. See if it clears the breakout price in above average volume. 
Via Investor's Business Daily
News headline image
Canaccord Genuity Maintains Buy Rating for Evolent Health: Here's What You Need To Know ↗
Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00. Shares of Evolent Health are trading down 2.43% over the last 24... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022 ↗
Upgrades 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Friday ↗
Jefferies cut the price target on MEI Pharma, Inc. (NASDAQ: MEIP) from $4 to $1. MEI Pharma shares fell 44.2% to $1.01 in pre-market trading. 
Via Benzinga
News headline image
Tough Slogging Ahead for Investors, Diversification is Important ↗
Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.